4.7 Article

Prolongation of disease-free life: When is the benefit sufficient to warrant the effort of taking a preventive medicine?

Journal

PREVENTIVE MEDICINE
Volume 154, Issue -, Pages -

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ypmed.2021.106867

Keywords

Benefit perception; Non-communicable disease; Preventive treatment; Primary prevention; Prolongation of disease-free life; Risk communication; Secondary prevention; Treatment benefit

Ask authors/readers for more resources

The minimum benefit required for individuals aged 50-80 years to accept a preventive treatment in terms of prolongation of a disease-free life (PODL) varies widely, with most people requiring a PODL of over 2 years. Factors such as education, income, age, and smoking status are associated with the requested minimum benefit. Most individuals require larger health benefits than average preventive medications can offer.
The prolongation of disease-free life (PODL) required by people to be willing to accept an offer of a preventive treatment is unknown. Quantifying the required benefits could guide information and discussions about preventive treatment. In this study, we investigated how large the benefit in prolongation of a disease-free life (PODL) should be for individuals aged 50-80 years to accept a preventive treatment offer. We used a crosssectional survey design based on a representative sample of 6847 Danish citizens aged 50-80 years. Data were collected in 2019 through a web-based standardized questionnaire administered by Statistics Denmark, and socio-demographic data were added from a national registry. We analyzed the data with chi-square tests and stepwise multinomial logistic regression. The results indicate that the required minimum benefit from the preventive treatment varied widely between individuals (1-week PODL = 14.8%, >4 years PODL = 39.2%), and that the majority of individuals (51.1%) required a PODL of >2 years. The multivariable analysis indicate that education and income were independently and negatively associated with requested minimum benefit, while age and smoking were independently and positively associated with requested minimum benefit to accept the preventive treatment. Most individuals aged 50-80 years required larger health benefits than most preventive medications on average can offer. The data support the need for educating patients and health care professionals on how to use average benefits when discussing treatment benefits, especially for primary prevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available